Works matching IS 1470269X AND DT 2015 AND VI 15 AND IP 1

Results: 15

An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 6, doi. 10.1038/tpj.2014.51

By:

Meadows, N A;
Morrison, A;
Brindley, D A;
Schuh, A;
Barker, R W

Publication type:

Article

Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 101, doi. 10.1038/tpj.2014.39

By:

Tekola-Ayele, F;
Adeyemo, A;
Aseffa, A;
Hailu, E;
Finan, C;
Davey, G;
Rotimi, C N;
Newport, M J

Publication type:

Article

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 69, doi. 10.1038/tpj.2014.40

By:

Volz, N B;
Stintzing, S;
Zhang, W;
Yang, D;
Ning, Y;
Wakatsuki, T;
El-Khoueiry, R E;
Li, J E;
Kardosh, A;
Loupakis, F;
Cremolini, C;
Falcone, A;
Scherer, S J;
Lenz, H-J

Publication type:

Article

Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 20, doi. 10.1038/tpj.2014.28

By:

Depta, J P;
Lenzini, P A;
Lanfear, D E;
Wang, T Y;
Spertus, J A;
Bach, R G;
Cresci, S

Publication type:

Article

Management and return of incidental genomic findings in clinical trials.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 1, doi. 10.1038/tpj.2014.62

By:

Ayuso, C;
Millan, J M;
Dal-Re, R

Publication type:

Article

Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 55, doi. 10.1038/tpj.2014.41

By:

Ellis, K L;
Zhou, Y;
Beshansky, J R;
Ainehsazan, E;
Yang, Y;
Selker, H P;
Huggins, G S;
Cupples, L A;
Peter, I

Publication type:

Article

Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 26, doi. 10.1038/tpj.2014.30

By:

Takahashi, M;
Saito, T;
Ito, M;
Tsukada, C;
Katono, Y;
Hosono, H;
Maekawa, M;
Shimada, M;
Mano, N;
Oda, A;
Hirasawa, N;
Hiratsuka, M

Publication type:

Article

Impact of GATA4 variants on stable warfarin doses in patients with prosthetic heart valves.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 33, doi. 10.1038/tpj.2014.36

By:

Jeong, E;
Lee, K E;
Jeong, H;
Chang, B C;
Gwak, H S

Publication type:

Article

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 84, doi. 10.1038/tpj.2014.34

By:

Saladores, P;
Mürdter, T;
Eccles, D;
Chowbay, B;
Zgheib, N K;
Winter, S;
Ganchev, B;
Eccles, B;
Gerty, S;
Tfayli, A;
Lim, J S L;
Yap, Y S;
Ng, R C H;
Wong, N S;
Dent, R;
Habbal, M Z;
Schaeffeler, E;
Eichelbaum, M;
Schroth, W;
Schwab, M

Publication type:

Article

Interaction between the Val158Met catechol-O-methyltransferase gene variant and second-generation antipsychotic treatment on blood pressure in children.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 95, doi. 10.1038/tpj.2014.35

By:

Cote, A T;
Panagiotopoulos, C;
Devlin, A M

Publication type:

Article

Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 38, doi. 10.1038/tpj.2014.38

By:

Rojas, L;
Neumann, I;
Herrero, M José;
Bosó, V;
Reig, J;
Poveda, J Luis;
Megías, J;
Bea, S;
Aliño, S F

Publication type:

Article

Therapeutic implications of novel mutations of the RFX6 gene associated with early-onset diabetes.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 49, doi. 10.1038/tpj.2014.37

By:

Artuso, R;
Provenzano, A;
Mazzinghi, B;
Giunti, L;
Palazzo, V;
Andreucci, E;
Blasetti, A;
Chiuri, R M;
Gianiorio, F E;
Mandich, P;
Monami, M;
Mannucci, E;
Giglio, S

Publication type:

Article

EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 77, doi. 10.1038/tpj.2014.33

By:

Sebio, A;
Salazar, J;
Páez, D;
Berenguer-Llergo, A;
del Río, E;
Tobeña, M;
Martín-Richard, M;
Sullivan, I;
Targarona, E;
Balart, J;
Baiget, M;
Barnadas, A

Publication type:

Article

Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 63, doi. 10.1038/tpj.2014.24

By:

Le Morvan, V;
Litière, S;
Laroche-Clary, A;
Ait-ouferoukh, S;
Bellott, R;
Messina, C;
Cameron, D;
Bonnefoi, H;
Robert, J

Publication type:

Article

Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 1, p. 13, doi. 10.1038/tpj.2014.29

By:

Lachance, K;
Korol, S;
O'Meara, E;
Ducharme, A;
Racine, N;
Liszkowski, M;
Rouleau, J L;
Pelletier, G B;
Carrier, M;
White, M;
de Denus, S

Publication type:

Article